Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

NCT01844700 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT01844700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01844700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Lead sponsor
Northwell Health
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2013
Completion date
April 30, 2014
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk mc4r genotype, low risk mc4r genotype, one week or less antipsychotic lifetime exposure